Drug-induced sleep endoscopy (DISE) represents a leading decision-making tool among sleep surgeons. Despite its broad acceptance, there remain several imitations such as variable interpretation of DISE findings. Following a formal introduction of DISE and overview of surgical options, a panel of highly experienced sleep surgeons will review several patient cases and discuss their proposed treatment plan. The panelists will share their insight in selecting from the spectrum of surgical options including soft tissue surgery, hypoglossal nerve stimulation, skeletal surgery, and tracheostomy.Learning Objectives: 1. Assess the role of drug-induced sleep endoscopy (DISE) for treatment of obstructive sleep apnea (OSA). 2. Summarize the breadth of surgical options for OSA. 3. Apply the DISE findings in the treatment planning of OSA patients.Faculty: Raj Dedhia, MD(Nothing to Disclose), Eric Kezirian, MD MPH(Intellectual Property Rights: Berendo Scientific; Magnap; Stock or Stock Options: Split Rock Scientific; Berendo Scientific; Cognition Life Science; Cryosa; Research funding: Inspire Medical Systems; Leadership Role: International Surgical Sleep Society; ReVENT Medical), B Tucker Woodson, MD(Royalty: Medtronic; Stock or Stock Options: Siesta Medical; Other: cryosa; Zelegant; Lingualflex; Research funding: Inspire Medical; Consulting Fees: Medtronic; Inspire Medical; Medrobotics), Edward Weaver, MD, MPH((Leadership Role: Dept. of Veterans& Affairs (VA); Dept. of Veterans & Affairs (VA); Laryngoscope; JAMA Oto HNS; American Academy of Sleep Medicine)).